The proposed method is intended to adjust the electrode potentials used in deep brain stimulation (DBS) with the consideration of both tissue transform and thermal effects caused by stimulation. During a typical DBS process, it is essential, for an effective treatment, to control the stimulation strength and region with varied applied electrode potentials. Some previous studies have been devoted for numerical simulations to find suitable electrode voltage levels for pre-desired stimulated strength and region. These studies consider only one of the two complexity factors due to the intrusion of the DBS lead: 1) a layer of extracellular fluid and giant cell often formed around the DBS leads, called the peri-electrode space and 2) thermal effects. These two factors should both be considered in finite element electromagnetic analysis (FEA), which provides the means to adjust electrode potential for the originally-desired DBS region-called the volume of tissue activated (VTA). Simulation results show that there should be a limiting stimulation voltage to meet the temperature constraint.
I. INTRODUCTION

D EEP BRAIN STIMULATION (DBS)
is a widely-used approach to treat varied brain diseases. This approach implants electrodes in a long-term fashion into selected brain targets to treat the symptoms of a number of neurological and other movement disorders, like Parkinson's disease (PD). Once the electrodes are implanted, an electrode-brain interface (EBI) will be formed. This EBI consists of three main components: the implanted electrode, the layer of peri-electrode space surrounding the electrode and the surrounding brain tissue. The peri-electrode space is filled with extracellular fluid at the acute stage during and immediately after implantation. For an extensive period of time (chronic stage), the peri-electrode space is eventually filled with giant cells, which are formed pathologically, since the electrode is implanted chronically [1] , [2] .
During DBS, it is essentially to control the volume of tissue activated (VTA), given certain electrode voltage applied. A satisfactory control of VTA is necessary for doctors to restrict the stimulated region to the originally-planned, while keeping other regions intact. Therefore, a number of past studies developed analysis/prediction methods to maintain the desired VTA [2] , [3] , while considering the aforementioned peri-electrode space at acute/chronic stages. These studies perform varied electromagnetic numerical analyses to find adjusted electrode voltage to compensate the effects of the growth of the peri-electrode space, often resulting in an increased voltage, due to a lower transfer coefficient of the space. However, these works did not consider that an increased voltage would lead to the temperature increase due to the Joule heat [4] . From hyperthermia therapies [4] [6] , [7] , somehow damaging neurons. Thus, this study investigates the dependence between stimulation voltage and thermal effect simultaneously with the prei-electrode space considered, also with the purpose not to exceed the aforementioned critical 38 C. A particular voltage adjustment methodology is proposed to maintain the same VTA at chronic stages as that in acute stage and to consider the thermal effect. The developed method ensures the quality of DBS treatment under the thermal effect consideration.
II. MATERIALS AND METHODS
A. Model Geometry
An EBI finite element model as shown in Fig. 1 is constructed and the resulted mesh is also shown in this figure. The model consists of three main components/regions [3] , [4] : the implanted electrode, the surrounding brain tissue, and the layer of peri-electrode space. Two types of Medtronic leads, Model 3387 and 3389 DBS leads, are considered in the EBI model simulation. Each of the 3387/3389 DBS leads contains four 1.5 mm-in-length electrodes, the radius of which is 0.635 mm. The only difference between two types of leads is the distance between electrodes (1.5 mm spacing for model 3387 DBS lead while 0.5 mm spacing for model 3389 DBS lead). On the other hand, the brain tissue considered as homogeneous and isotropic material, is modeled as a cylinder surrounding the electrode lead, with 5 cm radius and 14 cm height. The layer of peri-electrode space was defined as 0.25 mm thick, referring to [3] .
B. Bio-Heat Transfer Equation
The Pennes bio-heat transfer equation is used to explore the dependence between the stimulation voltage and the corresponding temperature in tissue, since it was widely popular in biomedicine [4] , [7] . This equation is described as follows: (1) where , , , and are the mass density, specific heat capacity, thermal conductivity, and temperature of tissue, respectively. In addition, is the blood density, and is the heat capacity of the blood. Finally, represents the body core temperature, is the blood perfusion, is the metabolic heat production in the tissue, and is the external heat source, i.e., the heat generation by DBS. In this work, is in fact , where and are the electrical conductivity of the tissue and the electrical potential induced by DBS, respectively, whose settings were based on an experienced EBI model. The technique of the finite element analysis (FEA) method is utilized herein to simulate the bio-heat transfer from the implanted electrodes to its surrounding tissue.
C. Simulation Parameters
Thermal-and electrical-related parameters based on [3] , [8] [9], to be used in this study, are listed in Tables I and II , respectively. In the bio-heat simulation environment, the initial temperature of the brain tissue is set as 37 C, the normal human body temperature. At the acute stage, the peri-electrode space was filled with extracellular fluid (ECF), the value of is 1.7 [S/m]. At the chronic stage, giant cells (GCs) was filled in the peri-electrode space, the value of is 0.125 [S/m], which was obtained from [3] . Prior to obtaining the temperature distribution, the Laplace's equation which follows from the full set of Maxwell's equation for electromagnetics under the condition that all time-derivatives are zero is used to compute the electrical potential distribution [3] . With solved temperature incorporated the electro-magnetic fields of the EBI model is simulated by using COMSOL Multiphysics 3.5.
III. RESULTS AND DISCUSSION
The objective of the study is to find the required stimulation voltage adjustment to maintain the same VTA at acute and chronic stages, with a further purpose-not to exceed the aforementioned critical 38 C in the peri-electrode space at both acute/chronic regions. The following are three procedure steps to achieve the simulation of the desired VTA. The first step is to simulate the electric potential distribution after implanting the DBS lead (Section III-A) at acute and chronic stages. The next step is to simulate the temperature distributions for different electric potential values (Section III-B) . Finally, the required stimulated voltage is adjusted to achieve the originally-expected VTA by considering the thermal effects (Section III-C). of time, the substance content of the peri-electrode space varied from extra-cellular fluid to giant cells. Since the electric conductivity of extra-cellular fluid (ECF) is higher than giant cells (GCs), it is often true that the volume of the tissue activated is larger at the acute stage than that at the chronic stage (due to a lower conductivity of GCs than ECF), also as shown in comparison between Figs. 2(a) , (c) and (b), (d). Fig. 3 presents the resulted electric potential distributions for the cross sections at electrodes, along the red "axial" on Fig. 2 . We set a hypothetical activation threshold voltage at 0.5 V, as referring to [3] for the critical potential at the boundary of VTA. In results, there should be a difference in the effective VTA between acute and chronic stages. It is seen from the results in Fig. 3(a) , (b) that with Model 3387 DBS lead, the distance from the electrode to the tissue activated (the VTA boundary) is 2.395 mm at the acute stage and 0.945 mm at the chronic stage. Under the same situation, it is seen from Fig. 3(c) , (d) that the distance from the electrode to the tissue activated was 2.535 mm at the acute stage and 0.905 mm at the chronic stage for Model 3389 DBS lead. Obviously, the volume of tissue (VTA) activated at the acute stage was larger than at the chronic stage. There was the same trend for both DBS leads. It means that if we want to maintain the same VTA level at the acute as chronic stages (i.e., the same quality of DBS treatment), increasing the stimulation voltage at the chronic stage is necessary. However, the quantity of voltage adjustment should be considered to avoid damage of tissue around the electrode due to unavoidable thermal effects. Thus, the next step is to explore the temperature distribution for the required stimulation voltage at the chronic stage, when a higher electrode voltage is required to achieve the same level of VTA as in the acute stage.
B. Temperature Distribution
The stimulation voltage was increased previously to the required level at the chronic stage, such that the VTA could be the same as at the acute stage. Utilizing the essential stimulation voltage, the corresponding temperature distribution was derived from the Pennes bio-heat transfer equation. Fig. 5(b) , the temperature increased to 39.16 C, indicating also a negative effect on the brain function.
In order to avoid unnecessary thermal damages, the appropriate stimulation voltage should be adjusted by considering thermal effects. Thus, the next step is developed to adjust the appropriate stimulation voltage and avoid the temperature increasing to 38 C.
C. Adjusting Stimulation Voltage
Brain function is especially sensitive to the changes in temperature. According to previous simulation results, we comprehended that if the stimulated distance from the electrode to the tissue activated is the same as that at the chronic stage, the value of stimulation voltage should be increased. However, the temperature should be limited below 38 C for safety consideration. By previous temperature model established, while the stimulation voltage is 2.23 V (2.27 V) at the chronic stage, the temperature is 38 C. In other words, the stimulation voltage ought to be kept below 2.23 V (2.27 V) at the chronic stage for avoiding brain damage for Model 3387 (3389) DBS lead. Thus, in the ensuing simulations, the stimulation voltage values at the acute stage are set as 0.25, 0.5, 0.75, 1, 1.25, and 1.561 V [5] .
Through the similar stimulation potential adjustment as shown in Sections III-A and III-B, Fig. 6 presents the analysis results for Model 3387 DBS lead, showing the original stimulation voltage for the acute stage and the adjusted stimulation voltage for the chronic stage. It is seen herein that if the stimulation voltage was approximately less than or equal to 1 V at the acute stage, the stimulation voltage at the chronic stage should be increased as about two times of that at the acute stage to achieve the same VTA. However, if the stimulation voltage at the acute stage is larger than 1 V, each corresponding stimulation voltage value at the chronic stage had to be adjusted to 2.2 V, less than two times, in order to meet the temperature constraint of 38 C. In this case, the VTA is of course less than required. Under the temperature limit (38 C), the required adjustment of stimulation voltage from the acute to chronic 
IV. CONCLUSION
A method is developed in this study to adjust the applied electrode voltage used in deep brain stimulation (DBS) with the consideration of tissue transform and thermal effects caused by stimulation. The adjustment guidelines are distilled from numerical electromagnetic simulations on electrical fields and temperature distribution. According to the simulation results, there is a limiting stimulation voltage to meet the temperature constraint at 38 C.
